World's Best Scientists 2026 revealed!
Therapeutic Advances in Chronic Disease
H-index 18

Therapeutic Advances in Chronic Disease

2040-6223

Published by: SAGE

https://journals.sagepub.com/home/taj

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 1958 44 38 13

Additional Metrics

Number of Best Scientists*: 84
Documents by Best Scientists*: 75
Top 100 Ranked Scientists*: 1
SCIMAGO H-index: 54
SCIMAGO SJR: 0.966
Impact Factor: 2.8

Overview

Top Research Topics at Therapeutic Advances in Chronic Disease?

The journal primarily tackles Internal medicine, Disease, Intensive care medicine, In patient and Gastroenterology. Endocrinology, Oncology and Cardiology are some topics wherein Internal medicine research discussed in the journal have an impact. Issues in Disease were discussed, taking into consideration concepts from other disciplines like Epidemiology and Immunology.

Therapeutic Advances in Chronic Disease facilitated presentations on Immunology research, particularly Pathogenesis and Immune system. The work tackled in the journal goes beyond the discipline of Intensive care medicine as it also encompasses Pharmacology. Therapeutic Advances in Chronic Disease tackles research in various disciplines, including In patient and Diabetes mellitus.

  • Internal medicine (37.27%)
  • Disease (15.68%)
  • Intensive care medicine (14.32%)

What are the most cited papers published in the journal?

  • Evidence for a protective effect of polyphenols-containing foods on cardiovascular health: an update for clinicians (170 citations)
  • Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary disease. (148 citations)
  • Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review (126 citations)

Research areas of the most cited articles at Therapeutic Advances in Chronic Disease:

The most cited papers primarily focus on research topics in Intensive care medicine, Disease, Pharmacology, Internal medicine and Alternative medicine. While work presented in the most cited publications provide substantial information on Pharmacology, it also covers topics in Diabetes mellitus, Regimen, Multiple sclerosis and Clinical trial. The most cited publications investigate Internal medicine research which frequently intersects with Gastroenterology.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Disease
  • Cancer

The previous edition focused in particular on these issues:

Internal medicine, In patient, Gastroenterology, Meta-analysis and Intensive care medicine are among the topics commonly tackled in the journal. It encompasses presentations on Internal medicine, specifically Disease and Cirrhosis. Therapeutic Advances in Chronic Disease explores research in Liver disease and overlapping concepts in Alpha 1-antitrypsin deficiency and Cause of death to expand the discourse in Cirrhosis.

Topics in Gastroenterology explored in Therapeutic Advances in Chronic Disease were investigated in conjunction with research in Biomarker (medicine), Type 2 diabetes, Type 2 Diabetes Mellitus and Fatty liver. While work presented in it provided substantial information on Meta-analysis, it also covered topics in Randomized controlled trial and Confidence interval. Therapeutic Advances in Chronic Disease focuses on Intensive care medicine research which is adjacent to topics in Transplantation.

The most cited articles from the last journal are:

  • The neurological symptoms of COVID-19: a systematic overview of systematic reviews, comparison with other neurological conditions and implications for healthcare services (4 citations)
  • Liver disease with unknown etiology - have you ruled out alpha-1 antitrypsin deficiency? (3 citations)
  • Management of lung disease in alpha-1 antitrypsin deficiency: what we do and what we do not know: (3 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Therapeutic Advances in Chronic Disease (based on the number of publications) are:

  • Jaymin B. Morjaria (8 papers) absent at the last edition,
  • Riccardo Polosa (8 papers) published 1 paper at the last edition the same number as at the previous edition,
  • Li Wang (5 papers) published 4 papers at the last edition,
  • Ruth Peters (5 papers) absent at the last edition,
  • Yuli Huang (5 papers) published 1 paper at the last edition, 3 less than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Therapeutic Advances in Chronic Disease (based on the number of publications) are:

  • University of Catania (15 papers) published 2 papers at the last edition, 2 less than at the previous edition,
  • Peking Union Medical College Hospital (11 papers) published 8 papers at the last edition, 6 more than at the previous edition,
  • Capital Medical University (10 papers) published 4 papers at the last edition, 1 less than at the previous edition,
  • National Taiwan University (10 papers) published 4 papers at the last edition, 2 more than at the previous edition,
  • Chang Gung University (8 papers) published 3 papers at the last edition, 1 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 4.04% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 24.21% were posted by at least one author from the top 10 institutions publishing in the journal. Another 3.16% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 23.16% of all publications and 49.47% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Opportunities in Health Institutions

A missing section that could enhance the depth of the article is one that discusses the career opportunities in the different scientific institutions or universities addressed in the previous sections, especially those connected with the journal "Therapeutic Advances in Chronic Disease". This would be particularly applicable to readers who are interested in these areas of study and are looking at potential job paths. There are a variety of job opportunities within the health institutions that contribute to "Therapeutic Advances in Chronic Disease". These range from being directly involved in research within a university setting or working as a health practitioner in a hospital associated with these academic institutions. For instance, many studies published in the journal involve clinical trials that could potentially facilitate nursing roles. Nurses play a significant part in managing and observing patient care during these trials. Therefore, an aspiring nurse could have a direct impact on life-changing research in chronic disease therapeutics. If you are specifically interested in a nursing career and are based in New Hampshire, you might find this guide on {anchor} useful. This guide offers a step-by-step process on how to become a nurse in New Hampshire, including the educational preparation and licensing procedures. Pursuing a career in a health institution allows you to contribute directly to the health and well-being of various patient populations while also participating in valuable and impactful research rightfully celebrated in "Therapeutic Advances in Chronic Disease". Remember to consider what role you are drawn to when you look at career opportunities in health institutions and how that aligns with your future aspirations and interests within the medical and research community. Make your impact on therapeutic advances in chronic disease by being part of these prestigious institutions.

Top Publications

  • Current smoking, former smoking, and adverse outcome among hospitalized COVID-19 patients: a systematic review and meta-analysis

    Konstantinos Farsalinos;Anastasia Barbouni;Konstantinos Poulas;Riccardo Polosa

    (2020)
    164 Citations
  • Nomenclature and clinical phenotypes of atopic dermatitis.

    Giampiero Girolomoni;Marjolein de Bruin-Weller;Valeria Aoki;Kenji Kabashima

    (2021)
    72 Citations
  • Flare management in atopic dermatitis: from definition to treatment

    (2022)
    34 Citations
  • Curcumin prevents chronic intermittent hypoxia-induced myocardial injury

    Sophie Moulin;Claire Arnaud;Sophie Bouyon;Jean-Louis Pépin

    (2020)
    33 Citations
  • Characteristics and outcomes of patients with chronic thromboembolic pulmonary hypertension in the era of modern therapeutic approaches: data from the Polish multicenter registry (BNP-PL).

    Grzegorz Kopeć;Olga Dzikowska-Diduch;Ewa Mroczek;Tatiana Mularek-Kubzdela

    (2021)
    29 Citations
  • Are apolipoprotein E fragments a promising new therapeutic target for Alzheimer’s disease?

    (2022)
    25 Citations
  • Alisol B 23-acetate attenuates CKD progression by regulating the renin–angiotensin system and gut–kidney axis:

    Hua Chen;Min-Chang Wang;Yuan-Yuan Chen;Lin Chen

    (2020)
    25 Citations
  • Association of vitamin D3 and its metabolites in patients with and without type 2 diabetes and their relationship to diabetes complications.

    Alexandra E Butler;Soha R Dargham;Aishah Latif;Haira R Mokhtar

    (2020)
    23 Citations
  • Feature selection from magnetic resonance imaging data in ALS: a systematic review.

    Thomas D. Kocar;Hans-Peter Müller;Albert C. Ludolph;Jan Kassubek

    (2021)
    20 Citations
  • The spectrum of clinical sequelae associated with alpha-1 antitrypsin deficiency:

    Vickram Tejwani;James K Stoller

    (2021)
    17 Citations

Related Online Degrees & Career Pathways

For those interested in Medicine in the USA, exploring related online degrees can open new avenues in healthcare careers. Programs like a health administration degree offer accelerated paths to leadership roles, blending business management skills with healthcare knowledge.

Affordability is key when choosing a program. Many students seek the online health management degree options that provide quality education without the heavy financial burden. These degrees support careers in managing healthcare organizations, policy-making, and improving patient care systems.

Nursing remains a critical field in healthcare. Prospective students can advance their clinical skills by enrolling in nurse practitioner courses online, which prepare them for expanded responsibilities and independent patient care roles.

For those starting their journey, selecting from the best online nursing programs offers a flexible and cost-effective option. These programs are designed to equip learners with essential skills for a variety of nursing careers while balancing other commitments.

Best Scientists Contributing to This Journal